Zealand Pharma has found a buyer for its V-Go insulin delivery device. Weeks after lackluster sales led it to seek a partner for the device, Zealand has agreed to offload the technology and associated ...

BRIDGEWATER, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device, announced today it ...

MannKind is acquiring Zealand Pharma’s wearable V-Go Insulin Delivery Device to expand its diabetes offerings. The deal is expected to close this month. The Danbury, CT-based company said it was ...

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of therapeutic products ...

Deal includes $10 million USD upfront payment to Zealand and sales-based milestones Certain inventory related to V-Go ® and employees also included under the terms of the deal Agreement is part of ...